Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
4.455
+0.125 (2.89%)
At close: Sep 26, 2025, 4:00 PM EDT
4.460
+0.005 (0.11%)
After-hours: Sep 26, 2025, 7:53 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $48.11 million as of September 26, 2025. Its market cap has increased by 20.14% in one year.
Market Cap
48.11M
Enterprise Value
32.35M
1-Year Change
20.14%
Ranking
Category
Stock Price
$4.46
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $48.11M, an increase of 58.63%. That is a compound annual growth rate of 9.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 48.11M | 39.85% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.91B |
| Johnson & Johnson | 425.60B |
| AbbVie | 386.59B |
| UnitedHealth Group | 313.74B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 229.20B |